Skip to main content

Pi Health Cancer Hospital

Turning research into hope, connecting you to possibilities

Navigating cancer treatment options can be challenging—but it doesn’t have to be, our clinical research center provides a seamless way for patients, caregivers, and healthcare providers to explore ongoing cancer clinical trials, understand your options and take a step toward potentially life-saving advancements in care.

Every clinical trial is a step towards progress, and by exploring these opportunities, you’re not only seeking care but you’re also contributing to the future of cancer treatment. Help us make a difference.

About this study

This study is for people with:

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

Number of participants

286 participants

Unique study ID

CTRI/2022/05/042831

Participation requirements

Open to both females and males
Open to people aged >18+

There are 9 locations for this study

How to apply

Fill the below form and our team will get in touch soon